Congenital Pulmonary Artery Anomalies: A Review and Approach to Classification

Leslie E Hirsig1, Priya G Sharma2, Nupur Verma3

  • 1Department of Radiology, Division of Pediatric Imaging, University of Florida College of Medicine, Gainesville, FL 32608, USA.

Insights

Congenital pulmonary artery anomalies are increasingly recognized due to advances in prenatal diagnosis and neonatal surgery. Understanding these rare conditions aids accurate diagnosis and surgical planning, improving patient outcomes.

Area of Science:

  • Cardiothoracic Imaging
  • Pediatric Cardiology
  • Congenital Heart Disease

Background:

  • Congenital pulmonary artery anomalies are rare but increasingly encountered.
  • Advances in prenatal diagnosis and neonatal surgery have improved outcomes.
  • Familiarity with these conditions is crucial for cardiothoracic imagers.

Purpose of the Study:

  • To provide a comprehensive overview of congenital pulmonary artery anomalies.
  • To highlight the importance of understanding etiology, classification, and associated conditions.
  • To emphasize the role of imaging in diagnosis and surgical planning.

Main Methods:

  • Review of current literature on congenital pulmonary artery anomalies.
  • Analysis of imaging findings across various modalities (e.g., echocardiography, CT, MRI).
  • Discussion of surgical management strategies and outcomes.

Main Results:

  • Congenital pulmonary artery anomalies require a multidisciplinary approach.
  • Accurate diagnosis relies on understanding diverse imaging presentations.
  • Early and precise surgical planning is key to successful management.

Conclusions:

  • Improved diagnostic and surgical capabilities have led to more patients surviving into adulthood.
  • Cardiothoracic imagers play a vital role in the timely diagnosis and management of these anomalies.
  • A thorough understanding of congenital pulmonary artery anomalies improves patient care and surgical planning.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
659
Review and Preview01:10

Review and Preview

In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.4K
Review and Preview01:13

Review and Preview

Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
11.5K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
613
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
471
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
509